Jodie A. Schildkraut
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Guiding principles for pragmatic randomised trials of tuberculosis treatments.
Journal: The Lancet. Infectious diseases
Published: March 30, 2026
A viable but nonculturable state of Mycobacterium avium in response to macrolide antibiotics: a recipe for relapses?
Journal: Journal of medical microbiology
Published: October 30, 2025
The role of the UNITE4TB Young Investigators Group in empowering early career researchers through mentorship, capacity building, and innovation.
Journal: IJTLD open
Published: October 07, 2025
Rising bedaquiline resistance: exploring potential causes and next steps.
Journal: The European respiratory journal
Published: July 21, 2025
Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB.
Journal: The Journal of antimicrobial chemotherapy
Published: March 03, 2025
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial.
Journal: The Lancet. Infectious diseases
Published: December 06, 2024
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial.
Journal: The Lancet. Infectious diseases
Published: December 06, 2024
Advances in tuberculosis biomarkers: unravelling risk factors, active disease and treatment success.
Advances in tuberculosis biomarkers: unravelling risk factors, active disease and treatment success.
Journal: Breathe (Sheffield, England)
Published: March 20, 2024
If you want to go far, go together: standardisation and data sharing in TB drug development.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: January 04, 2024
Replacing rifampicin with minocycline increases the activity of the treatment regimen for Mycobacterium avium complex pulmonary disease in a dynamic hollow-fibre system.
Journal: International journal of antimicrobial agents
Published: December 18, 2023
The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease.
Journal: Antimicrobial agents and chemotherapy
Published: October 25, 2023
Last Updated: 09/26/2026